White paper: Streamlining Pharma Operations in the Wake of COVID-19

Published: 13-Oct-2020 Featured companies: NSF
Regulatory

COVID-19 is shedding further light on pharmaceutical sourcing strategies and their inherent complexity, explains Jim Morris

White paper: Streamlining Pharma Operations in the Wake of COVID-19

NSF's white paper from Jim Morris discusses the importance of streamlining pharma operations in a COVID-19 environment.

He highlights the vital areas that will warrant leadership attention including supplier oversight, inspection readiness and the impact on personnel.

Click here to download the white paper.

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Regulatory
NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development

NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development

Read more
The discussion underscored the growing importance of aligning employee behaviours with compliance objectives, while also addressing the industry’s ongoing challenges around regulatory benchmarking and operational consistency

Trending Articles

Relevant companies

See more

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Regulatory
NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development

NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development

The discussion underscored the growing importance of aligning employee behaviours with compliance objectives, while also addressing the industry’s ongoing challenges around regulatory benchmarking and operational consistency
Regulatory
How to optimise your quality culture and maturity for success

How to optimise your quality culture and maturity for success

Explore NSF’s framework for aligning culture, leadership and systems to strengthen compliance, improve employee engagement and reduce risks
Regulatory
What to expect from a regulatory inspection: An NSF expert guide

What to expect from a regulatory inspection: An NSF expert guide

Prepare with confidence. NSF’s expert guide shows what inspectors look for, common pitfalls and how to ensure lasting inspection readiness
Manufacturing
FDA inspections and Form 483 responses: What companies need to know

FDA inspections and Form 483 responses: What companies need to know

NSF experts explain how companies can strengthen Form 483 responses, improve CAPA planning and reduce regulatory risk following FDA inspections
Manufacturing
NSF announces fourth annual Pharma Biotech Conference 2026

NSF announces fourth annual Pharma Biotech Conference 2026

Industry leaders to explore how pharma and biotech companies can build resilient quality systems beyond compliance
Manufacturing
How the QA and QP talent market is changing in pharma

How the QA and QP talent market is changing in pharma

Recruiting and retaining experienced quality and regulatory professionals has become significantly more complex for pharmaceutical and biotech companies
Regulatory
How the QA and QP Talent Market Is Changing in Pharma: Insights from Compliance Unlocked Podcast

How the QA and QP Talent Market Is Changing in Pharma: Insights from Compliance Unlocked Podcast

Recruiting and retaining experienced quality and regulatory professionals has become significantly more complex for pharmaceutical and biotech companies
Subscribe now